ロード中...
Bioequivalence studies for levothyroxine
The Food and Drug Administration (FDA) Guidance for Bioavailability and Bioequivalence Studies for Levothyroxine has been challenged by companies that manufacture brand-name products. Their contention is that the current guidance does not adequately address the endogenous background levels of the dr...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer-Verlag
2005
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2751496/ https://ncbi.nlm.nih.gov/pubmed/16146349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/aapsj070106 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|